These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 30366788

  • 21. Synthesis, molecular docking and kinetic studies of novel quinolinyl based acyl thioureas as mushroom tyrosinase inhibitors and free radical scavengers.
    Mustafa MN, Saeed A, Channar PA, Larik FA, Zain-Ul Abideen M, Shabir G, Abbas Q, Hassan M, Raza H, Seo SY.
    Bioorg Chem; 2019 Sep; 90():103063. PubMed ID: 31220666
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Discovery of (E)-3-(4-chlorophenyl)-N-(5-hydroxypentyl)acrylamide among N-substituted cinnamamide derivatives as a novel cosmetic ingredient for hyperpigmentation.
    Gunia-Krzyżak A, Popiół J, Słoczyńska K, Żelaszczyk D, Koczurkiewicz-Adamczyk P, Wójcik-Pszczoła K, Bucki A, Sapa M, Kasza P, Borczuch-Kostańska M, Marona H, Pękala E.
    Bioorg Chem; 2024 Sep; 150():107533. PubMed ID: 38878750
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A novel synthesized tyrosinase inhibitor: (E)-2-((2,4-dihydroxyphenyl)diazenyl)phenyl 4-methylbenzenesulfonate as an azo-resveratrol analog.
    Bae SJ, Ha YM, Kim JA, Park JY, Ha TK, Park D, Chun P, Park NH, Moon HR, Chung HY.
    Biosci Biotechnol Biochem; 2013 Sep; 77(1):65-72. PubMed ID: 23291747
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of the Novel Synthetic Tyrosinase Inhibitor (Z)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) In Vitro and In Silico.
    Bang E, Noh SG, Ha S, Jung HJ, Kim DH, Lee AK, Hyun MK, Kang D, Lee S, Park C, Moon HR, Chung HY.
    Molecules; 2018 Dec 13; 23(12):. PubMed ID: 30551624
    [Abstract] [Full Text] [Related]

  • 30. Acetazolamide Inhibits the Level of Tyrosinase and Melanin: An Enzyme Kinetic, In Vitro, In Vivo, and In Silico Studies.
    Abbas Q, Raza H, Hassan M, Phull AR, Kim SJ, Seo SY.
    Chem Biodivers; 2017 Sep 13; 14(9):. PubMed ID: 28557244
    [Abstract] [Full Text] [Related]

  • 31. Inhibitory properties of aromatic thiosemicarbazones on mushroom tyrosinase: Synthesis, kinetic studies, molecular docking and effectiveness in melanogenesis inhibition.
    Hałdys K, Goldeman W, Jewgiński M, Wolińska E, Anger N, Rossowska J, Latajka R.
    Bioorg Chem; 2018 Dec 13; 81():577-586. PubMed ID: 30248509
    [Abstract] [Full Text] [Related]

  • 32. Tyrosinase inhibitory activities of cinnamic acid analogues.
    Takahashi T, Miyazawa M.
    Pharmazie; 2010 Dec 13; 65(12):913-8. PubMed ID: 21284262
    [Abstract] [Full Text] [Related]

  • 33. Design, synthesis and biological evaluation of hydroxy substituted amino chalcone compounds for antityrosinase activity in B16 cells.
    Radhakrishnan S, Shimmon R, Conn C, Baker A.
    Bioorg Chem; 2015 Oct 13; 62():117-23. PubMed ID: 26333206
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Design, synthesis, and antimelanogenic effects of (2-substituted phenyl-1,3-dithiolan-4-yl)methanol derivatives.
    Kim DH, Kim SJ, Ullah S, Yun HY, Chun P, Moon HR.
    Drug Des Devel Ther; 2017 Oct 13; 11():827-836. PubMed ID: 28352157
    [Abstract] [Full Text] [Related]

  • 36. (E)-1-(Furan-2-yl)-(substituted phenyl)prop-2-en-1-one Derivatives as Tyrosinase Inhibitors and Melanogenesis Inhibition: An In Vitro and In Silico Study.
    Jung HJ, Noh SG, Ryu IY, Park C, Lee JY, Chun P, Moon HR, Chung HY.
    Molecules; 2020 Nov 21; 25(22):. PubMed ID: 33233397
    [Abstract] [Full Text] [Related]

  • 37. Synthesis and preliminary in vitro biological evaluation of 5-chloro-2-(substituted phenyl)benzo[d]thiazole derivatives designed as novel antimelanogenesis agents.
    Ha YM, Uehara Y, Park D, Jeong HO, Park JY, Park YJ, Lee JY, Lee HJ, Song YM, Moon HR, Chung HY.
    Appl Biochem Biotechnol; 2012 Nov 21; 168(6):1416-33. PubMed ID: 22968587
    [Abstract] [Full Text] [Related]

  • 38. Design, synthesis, kinetic mechanism and molecular docking studies of novel 1-pentanoyl-3-arylthioureas as inhibitors of mushroom tyrosinase and free radical scavengers.
    Larik FA, Saeed A, Channar PA, Muqadar U, Abbas Q, Hassan M, Seo SY, Bolte M.
    Eur J Med Chem; 2017 Dec 01; 141():273-281. PubMed ID: 29040952
    [Abstract] [Full Text] [Related]

  • 39. Exploring 2-mercapto-N-arylacetamide analogs as promising anti-melanogenic agents: in vitro and in vivo evaluation.
    Jung HJ, Park HS, Kim HJ, Park HS, Kim YE, Jeong DE, Noh SG, Park Y, Chun P, Chung HY, Moon HR.
    Org Biomol Chem; 2024 Sep 25; 22(37):7671-7689. PubMed ID: 39222053
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of in vitro and in vivo anti-melanogenic activity of a newly synthesized strong tyrosinase inhibitor (E)-3-(2,4 dihydroxybenzylidene)pyrrolidine-2,5-dione (3-DBP).
    Chung KW, Park YJ, Choi YJ, Park MH, Ha YM, Uehara Y, Yoon JH, Chun P, Moon HR, Chung HY.
    Biochim Biophys Acta; 2012 Jul 25; 1820(7):962-9. PubMed ID: 22498140
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.